Category: Biomarkers
North America Biomarkers
-
U.S. Prostate Cancer Testing Market - A Country Analysis: Focus on Type of Biomarker, Application, End User, and Region - Analysis and Forecast, 2022-2030
... testing market is anticipated to reach $1,901.6 million in 2030 from $544.1 million in 2021, with a CAGR of 14.7%, during the forecast period 2022-2030. The growth in the U.S. prostate cancer testing market is ... Read More
-
Global Metabolomics Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Product and Services (Metabolomics Instrument, Metabolomics bioinformatics tools and services), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Metabolic Disorders), Application (Biomarker Discovery, Toxicology, Nutrigenomics, Personalized Medicine, Drug Discovery, Functional Genomics) and Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
... Discovery, Toxicology, Nutrigenomics, Personalized Medicine, Drug Discovery, Functional Genomics) and Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) Market Overview: The scientific study of chemical processes, including metabolites, is known as ... Read More
-
Global Biomarkers Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Type (Molecular, Radiographic, Histologic, Physiologic), Application (Disease Susceptibility/Risk, Diagnostic, Drug Discovery & Development, Personalized Medicine, and Others), Disease (Oncology, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders) and Regions (North America, Asia Pacific, Europe, Latin America Middle East and Africa)
... Disorders) and Regions (North America, Asia Pacific, Europe, Latin America Middle East and Africa) Market Overview: Biomarkers are biological measures used to conduct a diagnostic evaluation, such as blood pressure or cholesterol level, as well ... Read More
-
U.S. Contract Research Organization (CROs) Market, by Service Type (Drug Discovery, Preclinical studies, Early Phase I – IIa, Phase IIa – III, Phase IIIb – IV, Drug Development, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small Size, Medium Size, and Large Size)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small ... Read More
-
Small Animal Imaging Market, by Product Type (Optical Imaging Systems {Bioluminescence/Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems, and X-Ray/Optical Imaging Systems}, Nuclear Imaging Systems {Micro-PET (Positron Emission Tomography) Systems, Micro-SPECT (Single-Photon Emission Computed Tomography) Systems, and Trimodality (SPECT/PET/CT) Systems}, MRI (Magnetic Resonance Imaging) Systems, Ultrasound Systems, CT (Computed Tomography) Systems, and Others {Photoacoustic Imaging Systems and Magnetic Particle Imaging (MPI) Systems, among others}), by Application (Monitoring Drug Treatment Response, Bio-distribution Studies, Cancer Cell Detection, Biomarkers, and Others {Longitudinal Studies and Epigenetics, among others}), by End User (Biotechnology and Pharmaceutical Companies, Academic/ Research Institutes, and Others {Contract Research Organizations, Laboratories, among others}), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and
... and Trimodality (SPECT/PET/CT) Systems}, MRI (Magnetic Resonance Imaging) Systems, Ultrasound Systems, CT (Computed Tomography) Systems, and Others {Photoacoustic Imaging Systems and Magnetic Particle Imaging (MPI) Systems, among others}), by Application (Monitoring Drug Treatment Response, Bio-distribution ... Read More
-
2022-2026 Mexico Cancer Diagnostics Market - Sales and Market Shares for Reagent and Instrument Suppliers, Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new ... Read More
-
2022-2026 Global Cancer Diagnostics Market in the USA, Europe, Japan - Sales and Market Shares for Reagent and Instrument Suppliers, Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... LeadingMarketResearch.com provides information and analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of ... Read More
-
2022-2026 Canada Cancer Diagnostics Market - Sales and Market Shares for Reagent and Instrument Suppliers, Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new ... Read More
-
2022-2026 North America Cancer Diagnostics Market in the USA, Canada, Mexico - Sales and Market Shares for Reagent and Instrument Suppliers, Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... from LeadingMarketResearch.com provides information and analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists ... Read More
-
United States Liquid Biopsy Market, By Product & Services (Assay Kits, Instruments, Services), By Circulating Biomarker (Circulating Tumor Cells, Circulating Tumor DNA (ctDNA), Cell-free DNA (cfDNA), Others), By Technology (Multi-gene Parallel Analysis using NGS v/s Single-gene Analysis using PCR Microarrays), By Application (Cancer v/s Non-Cancer), By End User (Hospitals & Clinics, Reference Laboratories, Others), By Region, Competition Forecast & Opportunities, 2027
... Single-gene Analysis using PCR Microarrays), By Application (Cancer v/s Non-Cancer), By End User (Hospitals & Clinics, Reference Laboratories, Others), By Region, Competition Forecast & Opportunities, 2027 The United States liquid biopsy market is projected to ... Read More
-
North America Veterinary Biomarkers Market Size, Share & Industry Trends Analysis Report By Animal Type, By Disease Type, By Product Type (Biomarkers, Kits & Reagents and Biomarker Readers), By Application, By Country and Growth Forecast, 2022 - 2028
... 2022 - 2028 The North America Veterinary Biomarkers Market would witness market growth of 11.1% CAGR during the forecast period (2022-2028). The species, breed, sex, and age of the animal should be identified on a ... Read More
-
Global Liquid Biopsy Market, By Sampling Type (Blood Sampling, Urine Sampling, Saliva Sampling, and Other Tissue Fluids Sampling), By Product and Service (Assay Kits, Instruments, and Services), By Circulating Biomarker (Circulating Tumor Cells, Circulating Tumor DNA), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By Application (Cancer Applications, Non-Cancer Applications), By End User (Reference Laboratories, Hospitals, Physician Laboratories, Academic Researchers, and Others), By Region (North America, Europe, The Asia Pacific, Latin America, and The Middle East and Africa)Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... DNA), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By Application (Cancer Applications, Non-Cancer Applications), By End User (Reference Laboratories, Hospitals, Physician Laboratories, Academic Researchers, and Others), By Region (North America, ... Read More
-
2022-2026 U.S. Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the U.S. cancer diagnostics market during the next five years. The report examines trends in the U.S. cancer diagnostics markets, ... Read More
-
2022-2026 Global Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities - USA, Europe, Japan - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the ... Read More
-
2022-2026 North America Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities - USA, Canada, Mexico - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as ... Read More
-
Cancer Biomarkers Market, by Biomarker Type (Protein Biomarkers, Genetic Biomarkers, and Other Cancer Biomarkers), by Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Kidney Cancer, Liver Cancer, and Other Cancers), by End User (Hospitals, Academic and Cancer Research Institutes, Ambulatory Surgical Centers, and Cancer Diagnostic Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... and Cancer Research Institutes, Ambulatory Surgical Centers, and Cancer Diagnostic Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 ... Read More
-
2022-2026 Canada Cancer Diagnostics Market Database - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and ... Read More
-
2022-2026 Global Cancer Diagnostics Market Database for the USA, Europe, Japan - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... information and analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing ... Read More
-
2022-2026 US Cancer Diagnostics Market Database - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and ... Read More
-
2022-2026 Mexico Cancer Diagnostics Market Database - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and ... Read More
-
2022-2026 North America Cancer Diagnostics Market Database for the USA, Canada, Mexico - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... provides information and analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies ... Read More
-
U.S. Solid Tumor Testing Market - A Country Analysis: Focus on Technology, Cancer Type, Type of Biomarker, By Application, by End User, and Region - Analysis and Forecast, 2022-2032
... Overview The U.S. solid tumor testing market was estimated to be at $9,498.8 million in 2021, which is expected to grow with a CAGR of 6.19% during the forecast period 2022-2032 and reach $18,287.6 million ... Read More
-
Bioanalytical Testing Services Market by Type, Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User and Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2027
... for the detailed examination of biological and biotechnology products. Bioanalysis enables the quantitative measurement of drugs and their metabolites, biological molecules in unnatural locations or concentrations, DNA, and large molecules. The global bioanalytical testing services ... Read More
-
2022-2026 Canada Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... Read More
-
2022-2026 North America Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersUS, Canada, MexicoSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... new 3-country report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging ... Read More
Research Assistance
